|1.||Booij, Jan: 15 articles (03/2015 - 06/2005)|
|2.||Antonini, Angelo: 14 articles (08/2014 - 03/2006)|
|3.||Bressan, Rodrigo A: 12 articles (01/2014 - 01/2009)|
|4.||Pezzoli, Gianni: 10 articles (09/2014 - 03/2006)|
|5.||Tatsch, Klaus: 10 articles (01/2013 - 06/2002)|
|6.||Scherfler, Christoph: 9 articles (11/2012 - 10/2003)|
|7.||Tatsch, K: 9 articles (01/2007 - 02/2000)|
|8.||Poewe, Werner: 8 articles (06/2015 - 10/2003)|
|9.||Isaias, Ioannis U: 8 articles (01/2015 - 08/2006)|
|10.||Cilia, Roberto: 8 articles (09/2014 - 03/2006)|
|1.||Parkinson Disease (Parkinson's Disease)
11/01/2012 - "We found that in the right-handed Parkinson's disease cohort, the number of patients who had lower dopamine transporter uptake in the left posterior putamen was significantly greater compared with those with lower uptake in the right posterior putamen (Parkinson's disease-left group, n = 49; Parkinson's disease-right group, n = 19; P < 0.001). "
10/10/2006 - "Cr improved patient mood and led to a smaller dose increase of dopaminergic therapy but had no effect on overall Unified Parkinson's Disease Rating Scale scores or dopamine transporter SPECT."
01/01/2014 - "Disclosure of imaging information resulted in improved understanding of parkinsonian symptoms in nearly half of subjects, and less belief among 'no dopamine transporter deficit' subjects that they had a diagnosis of Parkinson disease."
05/15/2003 - "The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients."
11/01/2015 - "This study was designed to test this theory of oxidative damage in an animal model of Parkinson's disease, using a transgenic strain of zebrafish with fluorescent labeling of cells that express the dopamine transporter. "
|2.||Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
06/01/2002 - "Eleven adult patients with attention deficit hyperactivity disorder (ADHD) without medication, consuming 7-40 cigarettes per day, showed statistically significant lower values for striatal dopamine transporter (DAT) measured by [99mTc]TRODAT-1 SPECT compared to 11 non-smoking drug-naive patients with ADHD, matched for sex and age, despite higher ADHD scores for the smokers. "
01/01/2006 - "The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder."
07/15/2013 - "The main aim of this study was to examine the relationship between dopamine transporter (DAT) binding in the striatum in individuals with and without attention-deficit/hyperactivity disorder (ADHD), attending to the 3'-untranslated region of the gene (3'-UTR) and intron8 variable number of tandem repeats (VNTR) polymorphisms of the DAT (SLC6A3) gene. "
06/01/2009 - "The dopamine transporter locus (DAT1) has been studied as a risk factor for attention-deficit/hyperactivity disorder (ADHD) and in pharmacogenetic studies of stimulant response. "
01/01/2009 - "Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder."
|3.||Schizophrenia (Dementia Praecox)
07/01/2014 - "P300 waveform and dopamine transporter availability: a controlled EEG and SPECT study in medication-naive patients with schizophrenia and a meta-analysis."
03/01/2013 - "Our study aimed to compare dopamine transporter (DAT) availability between drug-naive patients with schizophrenia and controls using SPECT. "
03/01/2013 - "Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis."
10/31/2011 - "A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients."
02/01/2010 - "Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study."
|4.||Parkinsonian Disorders (Parkinsonism)
01/01/2004 - "The SPECT imaging of the dopamine transporter with [(99m)Tc]TRODAT-1 is helpful in differentiating DRD from early-onset idiopathic parkinsonism. "
07/01/2013 - "The aim of the present study was to examine the striatal dopamine transporter (DAT) density in patients with parkinsonism and SAE. "
05/01/2010 - "Degenerative parkinsonism in patients with psychogenic parkinsonism: A dopamine transporter imaging study."
04/15/2010 - "In this study our aim was to evaluate patients with Clinically Unclear Parkinsonian Syndromes (CUPS) submitted to brain SPECT imaging using the technetium-99m labeled Dopamine Transporter (DAT) tracer TRODAT-1. "
10/01/2007 - "PINK1 mutation in Taiwanese early-onset parkinsonism : clinical, genetic, and dopamine transporter studies."
|5.||Cocaine-Related Disorders (Cocaine Addiction)
04/01/2012 - "Dopamine transporter (DAT) inhibitors have been developed as a promising treatment approach for cocaine dependence. "
01/01/2004 - "There have been many studies aimed at understanding the role that the dopamine transporter plays in cocaine abuse. "
01/01/2013 - "Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction."
07/13/2006 - "The dopamine transporter plays an important role in the molecular mechanism of cocaine dependence. "
03/21/2006 - "A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample."
|3.||2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropane
|4.||Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)
|5.||Levodopa (L Dopa)
|6.||Brain-Derived Neurotrophic Factor (BDNF)
|7.||Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)
|8.||Antipsychotic Agents (Antipsychotics)
|9.||Glial Cell Line-Derived Neurotrophic Factor (GDNF)
|10.||nestin (nestin protein)
|1.||Mesenchymal Stem Cell Transplantation
|3.||Transplantation (Transplant Recipients)
|4.||Drug Therapy (Chemotherapy)